Published in Acta Naturae on April 01, 2010
An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med (1992) 13.29
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS (1999) 3.04
Challenges in tuberculosis drug research and development. Nat Med (2007) 1.67
Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis. J Med Chem (2008) 1.21
2'-Deoxynucleoside 5'-triphosphates modified at alpha-, beta- and gamma-phosphates as substrates for DNA polymerases. Nucleic Acids Res (1998) 1.13
Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther (2008) 1.06
Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria. J Med Chem (2005) 0.99
[Examining the ex vivo growth in the macrophages of Mycobacterium tuberculosis of various genotypic clusters]. Probl Tuberk Bolezn Legk (2006) 0.90
[A new terminator of DNA biosynthesis--possible conformation analog of the substrate in a DNA-synthesizing complex]. Bioorg Khim (1987) 0.83
Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase. Verh K Acad Geneeskd Belg (2006) 0.83
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. J Med Chem (2007) 0.82
Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective. Adv Virus Res (2009) 0.81
Studies on acyclic pyrimidines as inhibitors of mycobacteria. Bioorg Med Chem (2006) 0.80
Dialogue between Mycobacterium tuberculosis and Homo sapiens. Tuberculosis (Edinb) (2001) 0.79
[New microbiological Techniques in diagnosis of tuberculosis]. Probl Tuberk (1996) 1.13
Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips. Bull Exp Biol Med (2008) 1.11
Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis (2012) 0.93
Mutants of T7 RNA polymerase that are able to synthesize both RNA and DNA. FEBS Lett (1995) 0.91
Deoxyribonucleotide-containing RNAs: a novel class of templates for HIV-1 reverse transcriptase. Nucleic Acids Res (1997) 0.90
Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. Eur J Clin Microbiol Infect Dis (2010) 0.90
[Examining the ex vivo growth in the macrophages of Mycobacterium tuberculosis of various genotypic clusters]. Probl Tuberk Bolezn Legk (2006) 0.90
Inactivation of bacteriophage T7 DNA-dependent RNA polymerase by 5'-p-fluorosulfonylbenzoyladenosine. Identification of the modification site and the effect of the modification on enzyme action. Eur J Biochem (1990) 0.87
[Non-hydrolysable analogs of inorganic pyrophosphate as inhibitors of hepatitis C virus RNA-dependent RNA-polymerase]. Bioorg Khim (2012) 0.87
Serodiagnosis of tuberculosis: detection of mycobacterial antibodies and antigens. Tuber Lung Dis (1996) 0.87
Structure and aminoacylation capacities of tRNA transcripts containing deoxyribonucleotides. RNA (1997) 0.87
Lys631 residue in the active site of the bacteriophage T7 RNA polymerase. Affinity labeling and site-directed mutagenesis. Eur J Biochem (1991) 0.86
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region]. Probl Tuberk Bolezn Legk (2005) 0.84
Human herpes simplex virus: life cycle and development of inhibitors. Biochemistry (Mosc) (2014) 0.84
[Genotypic characteristics of Mycobacterium tuberculosis strains from the Republic of Tyva]. Probl Tuberk Bolezn Legk (2004) 0.84
[Molecular genotyping of Mycobacterium tuberculosis strains isolated from patients in the Samara region by the restriction DNA fragment length polymorphism]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.83
[Characterization of hepatitis C virus structural proteins and HCV-like particles produced in recombinant baculovirus infected insect cells]. Mol Biol (Mosk) (2010) 0.82
Structural-functional analysis of bacteriophage T7 RNA polymerase. Biochemistry (Mosc) (2002) 0.82
Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP. FEBS Lett (1993) 0.81
Association of various genetic markers with tuberculosis and other lung diseases in Tuvinian children. Tuber Lung Dis (1996) 0.81
Detection of rifampicin-resistant Mycobacterium tuberculosis strains by hybridization and polymerase chain reaction on a specialized TB-microchip. Bull Exp Biol Med (2001) 0.81
Structure and function of protein kinase from pig brain. Adv Cyclic Nucleotide Res (1978) 0.81
The studies of cooperative regions in T7 RNA polymerase. FEBS Lett (1994) 0.80
[Purification and site-directed mutagenesis of DNA methyltransferase SssI]. Mol Biol (Mosk) (2007) 0.80
[New organizational forms of antituberculosis care under present conditions. Results and experience exchange of work in pilot regions. Scientific-and-Practical Conference (Moscow, September 25-27, 2002)]. Probl Tuberk (2003) 0.80
[Genetic system of selecting point mutations of bacteriophage T7 RNA polymerase]. Mol Biol (Mosk) (1992) 0.80
[Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia]. Mol Gen Mikrobiol Virusol (2000) 0.79
Targeted mutagenesis identifies Asp-569 as a catalytically critical residue in T7 RNA polymerase. Mol Gen Genet (1995) 0.79
Tyr-571 is involved in the T7 RNA polymerase binding to its promoter. FEBS Lett (1993) 0.79
Studies on the mechanism of action of histone kinase dependent on adenosine 3':5'-monophosphate. Evidence for involvement of histidine and lysine residues in the phosphotransferase reaction. Eur J Biochem (1977) 0.79
[Regularities in utilization of deoxyribonucleoside triphosphates by mutant forms of bacteriophage T7 RNA polymerase]. Mol Biol (Mosk) (1997) 0.79
Ex vivo production of interferon-gamma, tumor necrosis factor-alpha, and interleukin-6 by mouse macrophages during infection with M. bovis and M. tuberculosis H37Rv. Bull Exp Biol Med (2007) 0.79
Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System. Acta Naturae (2011) 0.79
[Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.79
Inhibition of HIV-1 reverse transcriptase by aryl-substituted naphto- and anthraquinones. Dokl Biochem Biophys (2002) 0.78
[Synthesis and antiviral evaluation against Vaccinia virus of new N¹-oxide analogues of 5'-noraristeromycin]. Bioorg Khim (2011) 0.78
[Role of N-linked glycans in HCV glycoprotein E1 in the folding of structural proteins and formation viral particles]. Mol Biol (Mosk) (2013) 0.78
Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits. AIDS Res Hum Retroviruses (2000) 0.77
[Interaction of Mycobacteria isolated from sarcoidosis patients with antituberculosis antibodies]. Probl Tuberk (1997) 0.77
[Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies]. Mol Biol (Mosk) (1992) 0.77
New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Biochemistry (Mosc) (2004) 0.77
[Impact of M. tuberculosis genotype on survival in mice with experimental tuberculosis]. Probl Tuberk Bolezn Legk (2007) 0.77
Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives. Biochemistry (Mosc) (2006) 0.77
[Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis]. Mol Biol (Mosk) (2012) 0.77
[Cellular defense systems against oxidative and ER stresses: mechanisms of regulation and influence of hepatitis C virus]. Mol Biol (Mosk) (2011) 0.77
[Antiherpesviral activity of acycloguanosine H-phosphonate in experiments using laboratory animals]. Vopr Virusol (2011) 0.77
[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region]. Probl Tuberk Bolezn Legk (2006) 0.77
Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase. FEBS Lett (1999) 0.77
Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes. Biochemistry (Mosc) (2014) 0.76
Synthesis of mixed ribo/deoxyribopolynucleotides by mutant T7 RNA polymerase. FEBS Lett (1998) 0.76
[Mycobacterium tuberculosis strain transmission caused by migratory processes in the Russian Federation (in case of populational migration from the Caucasian Region to Moscow and the Moscow Region)]. Probl Tuberk Bolezn Legk (2006) 0.76
DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge. Intervirology (2000) 0.76
[Transcription and its regulation in mammalian and human mitochondria]. Mol Biol (Mosk) (2009) 0.76
[Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs]. Mol Biol (Mosk) (2010) 0.76
[Biological properties of M. Tuberculosis W cluster strains]. Probl Tuberk Bolezn Legk (2008) 0.76
Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors. Biochemistry (Mosc) (2008) 0.75
Carbocyclic analogues of inosine-5'-monophosphate: synthesis and biological activity. Acta Naturae (2012) 0.75
The Interaction between the RNA-Dependent RNA-Polymerase of the Hepatitis Virus and RNA Matrices. Acta Naturae (2009) 0.75
Inhibition of DNA gyrase by levofloxacin and related fluorine-containing heterocyclic compounds. Acta Naturae (2011) 0.75
[The identification of the antigenic determinants of Mycobacterium leprae passed through laboratory animals by using monoclonal antibodies]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Effect of mouse antiserum against isologous aggregated immunoglobulins on the accumulation of rosette- and antibody-forming cells in mice immunized with ram erythrocytes]. Biull Eksp Biol Med (1978) 0.75
[Genotyping mycobacteria, isolated from incarcerated tuberculosis patients]. Probl Tuberk (2001) 0.75
[Comparative characterization of the antigenic composition of M. leprae and M. lufu]. Probl Tuberk (2001) 0.75
[Identification of mycobacteria in sputum by determining antigens in the culture medium]. Probl Tuberk (1994) 0.75
[Experience with fenazid in perperas with respiratory tuberculosis and post-tuberculous changes in the lung]. Probl Tuberk Bolezn Legk (2004) 0.75
[A study of bronchial patency in adolescents with spinal curvature of various etiology and degree of expression]. Ortop Travmatol Protez (1970) 0.75
[Preparation and characteristics of murine monoclonal antibodies to the Salmonella typhimurium K-antigen]. Biull Eksp Biol Med (1994) 0.75
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis]. Probl Tuberk (2002) 0.75
[Level and spectrum of tuberculosis antibodies in mice sensitive and resistant to tuberculosis]. Probl Tuberk (1993) 0.75
[Detection and characteristics of rpoB gene mutations in rifampicin-resistant clinical strains of M. tuberculosis]. Probl Tuberk (1999) 0.75
[Humoral immune response in humans and animals infected and immunized with Mycobacteria of the MAIS complex]. Probl Tuberk (1994) 0.75
[The comparative cultural-biochemical and immunochemical identification of laboratory strains of cultured mycobacteria from leprous patient lesions and from soil]. Probl Tuberk (2000) 0.75
[Role of PCR analysis in complex bacteriological studies in phthisiology]. Probl Tuberk (2001) 0.75
[Characterization of an experimental model of endogenously reactivated tuberculosis: detection of Mycobacterial DNA during chemotherapy]. Probl Tuberk (2002) 0.75
[Effect of antiserum against isologous aggregated immunoglobulins on the delayed-type hypersensitivity in mice immunized with sheep red blood cells]. Biull Eksp Biol Med (1979) 0.75
[Diagnosis of latent primary intrathoracic tuberculosis of respiratory system in the phase of calcification in children]. Probl Tuberk Bolezn Legk (2004) 0.75
[Specific antisera to mycobacteria]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Probl Tuberk Bolezn Legk (2004) 0.75
[Effect of antiserum against isologous aggregated immunoglobulins on synthesis of nonspecific immunoglobulins in mice immunized with sheep erythrocytes]. Biull Eksp Biol Med (1980) 0.75
[Comparative characterization of molecular and microbiological methods for controlling chemotherapy in new cases of pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2004) 0.75
[Characteristics of abacillary tuberculosis in school-age children and adolescents and laboratory methods of its diagnosis]. Probl Tuberk Bolezn Legk (2004) 0.75